Fabrice Barlési

4 ta ish

Institut Gustave Roussy

1. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

   Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas +40

   Maqola20223 iqtibos

   ABIABI:AkademIndex/2026.other.480530

2. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group

   Fernanda Mosele, Jordi Remón, Joaquı́n Mateo +19

   Sharh maqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.079148

3. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

   Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo +17

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.586467

4. Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

   Matthew D. Hellmann, Luis Paz‐Ares, Reyes Bernabe Caro +23

   Maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.826278